ALLIANCE trial and the combinations of CYP17 and AR inhibitors in CRPC

Dr. Nima Sharifi, MD at Cleveland Clinic discusses the ALLIANCE trial and the combinations of CYP17 and AR inhibitors in CRPC at ASCO GU 2016 in San francisco